Literature DB >> 19010895

MUC4, a multifunctional transmembrane glycoprotein, induces oncogenic transformation of NIH3T3 mouse fibroblast cells.

Sangeeta Bafna1, Ajay P Singh, Nicolas Moniaux, James D Eudy, Jane L Meza, Surinder K Batra.   

Abstract

Numerous studies have established the association of MUC4 with the progression of cancer and metastasis. An aberrant expression of MUC4 is reported in precancerous lesions, indicating its early involvement in the disease process; however, its precise role in cellular transformation has not been explored. MUC4 contains many unique domains and is proposed to affect cell signaling pathways and behavior of the tumor cells. In the present study, to decipher the oncogenic potential of MUC4, we stably expressed the MUC4 mucin in NIH3T3 mouse fibroblast cells. Stable ectopic expression of MUC4 resulted in increased growth, colony formation, and motility of NIH3T3 cells in vitro and tumor formation in nude mice when cells were injected s.c. Microarray analysis showed increased expression of several growth-associated and mitochondrial energy production-associated genes in MUC4-expressing NIH3T3 cells. In addition, expression of MUC4 in NIH3T3 cells resulted in enhanced levels of oncoprotein ErbB2 and its phosphorylated form (pY(1248)-ErbB2). In conclusion, our studies provide the first evidence that MUC4 alone induces cellular transformation and indicates a novel role of MUC4 in cancer biology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19010895      PMCID: PMC2610629          DOI: 10.1158/0008-5472.CAN-08-3135

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  41 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance.

Authors:  M Andrianifahanana; N Moniaux; B M Schmied; J Ringel; H Friess; M A Hollingsworth; M W Büchler; J P Aubert; S K Batra
Journal:  Clin Cancer Res       Date:  2001-12       Impact factor: 12.531

3.  Differential expression of ribosomal L31, Zis, gas-5 and mitochondrial mRNAs following oxidant induction of proliferative vascular smooth muscle cell phenotypes.

Authors:  K P Lu; N F Alejandro; K M Taylor; M M Joyce; T E Spencer; K S Ramos
Journal:  Atherosclerosis       Date:  2002-02       Impact factor: 5.162

4.  MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas.

Authors:  M Saitou; M Goto; M Horinouchi; S Tamada; K Nagata; T Hamada; M Osako; S Takao; S K Batra; T Aikou; K Imai; S Yonezawa
Journal:  J Clin Pathol       Date:  2005-08       Impact factor: 3.411

5.  Analysis of MUC4 mucin expression in lung carcinoma cells and its immunogenicity.

Authors:  J Hanaoka; K Kontani; S Sawai; M Ichinose; N Tezuka; S Inoue; S Fujino; I Ohkubo
Journal:  Cancer       Date:  2001-10-15       Impact factor: 6.860

6.  Cloning and characterization of the 5' flanking region of the sialomucin complex/rat Muc4 gene: promoter activity in cultured cells.

Authors:  S A Price-Schiavi; A Perez; R Barco; K L Carraway
Journal:  Biochem J       Date:  2000-07-15       Impact factor: 3.857

Review 7.  Muc4/sialomucin complex, the intramembrane ErbB2 ligand, in cancer and epithelia: to protect and to survive.

Authors:  Kermit L Carraway; Aymee Perez; Nebila Idris; Scott Jepson; Maria Arango; Masanobu Komatsu; Bushra Haq; Shari A Price-Schiavi; Jin Zhang; Coralie A Carothers Carraway
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2002

8.  MUC4 expression increases progressively in pancreatic intraepithelial neoplasia.

Authors:  Michael J Swartz; Surinder K Batra; Grish C Varshney; Michael A Hollingsworth; Charles J Yeo; John L Cameron; Robb E Wilentz; Ralph H Hruban; Pedram Argani
Journal:  Am J Clin Pathol       Date:  2002-05       Impact factor: 2.493

9.  Human DF3/MUC1 carcinoma-associated protein functions as an oncogene.

Authors:  Yongqing Li; Derek Liu; Dongshu Chen; Surender Kharbanda; Donald Kufe
Journal:  Oncogene       Date:  2003-09-04       Impact factor: 9.867

10.  Aberrant expression of MUC3 and MUC4 membrane-associated mucins and sialyl Le(x) antigen in pancreatic intraepithelial neoplasia.

Authors:  Hee-Ug Park; Jong-Woo Kim; Grace E Kim; Han-Ik Bae; Suzanne C Crawley; Stacey C Yang; James R Gum; Surinder K Batra; Karine Rousseau; Dallas M Swallow; Marvin H Sleisenger; Young S Kim
Journal:  Pancreas       Date:  2003-04       Impact factor: 3.327

View more
  30 in total

1.  Novel monoclonal antibodies against the proximal (carboxy-terminal) portions of MUC16.

Authors:  Thapi Dharma Rao; Kay J Park; Peter Smith-Jones; Alexia Iasonos; Irina Linkov; Robert A Soslow; David R Spriggs
Journal:  Appl Immunohistochem Mol Morphol       Date:  2010-10

Review 2.  Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells.

Authors:  S Bafna; S Kaur; S K Batra
Journal:  Oncogene       Date:  2010-03-29       Impact factor: 9.867

3.  Transforming activity of a novel mutant of HPV16 E6E7 fusion gene.

Authors:  Qiang Xie; Zhi-Xiang Zhou; Ze-Lin Li; Yi Zeng
Journal:  Virol Sin       Date:  2011-06-12       Impact factor: 4.327

Review 4.  Targeted immune therapy of ovarian cancer.

Authors:  Keith L Knutson; Lavakumar Karyampudi; Purushottam Lamichhane; Claudia Preston
Journal:  Cancer Metastasis Rev       Date:  2015-03       Impact factor: 9.264

5.  A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low-grade fibromyxoid sarcoma: a pathologic and molecular study of 18 cases.

Authors:  Carlos Prieto-Granada; Lei Zhang; Hsiao-Wei Chen; Yun-Shao Sung; Narasimhan P Agaram; Achim A Jungbluth; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2014-09-18       Impact factor: 5.006

Review 6.  MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma.

Authors:  Shailendra K Gautam; Sushil Kumar; Andrew Cannon; Bradley Hall; Rakesh Bhatia; Mohd Wasim Nasser; Sidharth Mahapatra; Surinder K Batra; Maneesh Jain
Journal:  Expert Opin Ther Targets       Date:  2017-05-29       Impact factor: 6.902

Review 7.  Pathogenesis of ovarian cancer: clues from selected overexpressed genes.

Authors:  Ie-Ming Shih; Ben Davidson
Journal:  Future Oncol       Date:  2009-12       Impact factor: 3.404

Review 8.  Review of the adenocarcinoma cell surface receptor for human alpha-fetoprotein; proposed identification of a widespread mucin as the tumor cell receptor.

Authors:  G J Mizejewski
Journal:  Tumour Biol       Date:  2013-02-28

Review 9.  Mucins in cancer: function, prognosis and therapy.

Authors:  Donald W Kufe
Journal:  Nat Rev Cancer       Date:  2009-12       Impact factor: 60.716

10.  Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin.

Authors:  S Bafna; S Kaur; N Momi; S K Batra
Journal:  Br J Cancer       Date:  2009-09-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.